Detalhe da pesquisa
1.
Late recurrence of lobular breast carcinoma presented as gastric metastasis.
Rev Esp Enferm Dig
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882182
2.
NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Clin Transl Med
; 14(2): e1554, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344872
3.
NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.
Res Sq
; 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886490
4.
Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.
bioRxiv
; 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712139
5.
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
Cells
; 12(15)2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566035
6.
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Breast
; 66: 77-84, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206609
7.
Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.
Cancer Res
; 80(23): 5216-5230, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023950
8.
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
Clin Breast Cancer
; 19(2): 105-112, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679100
9.
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach.
Genome Biol
; 16: 40, 2015 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853295
10.
Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer.
Clin Transl Oncol
; 7(8): 358-60, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16185606
11.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Clin Transl Oncol
; 11(11): 727-36, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917536
12.
Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer
Clin. transl. oncol. (Print)
; 7(8): 358-360, sept. 2005.
Artigo
em En
| IBECS (Espanha) | ID: ibc-040788